| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/25/2004 | DE19742117B4 Verfahren zur Messung von Harnstoffstickstoff und Untersuchungssets dafür A method for measurement of urea nitrogen and study sets for |
| 03/25/2004 | DE10242433A1 Chip carrying probes for specific genes, useful for rapid monitoring of organism status, particularly during fermentation |
| 03/25/2004 | DE10242359A1 Amplifying information from genetic material containing many fragments, useful e.g. for analyzing frequency of chromosomes in oocytes |
| 03/25/2004 | DE10242319A1 New double-stranded oligonucleotides, useful for treating e.g. cardiovascular disease and arthritis, are decoys that lift inhibition of expression of endothelial nitric oxide synthase |
| 03/25/2004 | DE10241938A1 Selecting specific-bonding nucleic acid, by a modified SELEX process that includes purification by ultrafiltration to facilitate automation |
| 03/25/2004 | DE10112387B4 Massenspektrometrische Genotypisierung Mass spectrometric genotyping |
| 03/25/2004 | CA2544124A1 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 03/25/2004 | CA2500967A1 Transgenic cancer models in fish |
| 03/25/2004 | CA2499245A1 Method and apparatus for sorting particles |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2499145A1 Food-borne pathogen and spoilage detection device and method |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498913A1 Assay stick comprising coded microbeads |
| 03/25/2004 | CA2498783A1 Method for detection of micro-metastasis |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498771A1 2',5'-oligoadenylate phosphodiesterase |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498751A1 Nell-1 enhanced bone mineralization |
| 03/25/2004 | CA2498746A1 Microarray synthesis and assembly of gene-length polynucleotides |
| 03/25/2004 | CA2498614A1 Analyzing nerve cell damage |
| 03/25/2004 | CA2498583A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | CA2498518A1 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | CA2498418A1 Gene segregation and biological sample classification methods |
| 03/25/2004 | CA2498414A1 Methods and systems for estimating the melting temperature (tm) for polynucleotide molecules |
| 03/25/2004 | CA2498411A1 Cell-based detection and differentiation of disease states |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497801A1 Paks as modifiers of the chk pathway and methods of use |
| 03/25/2004 | CA2497793A1 Flj20647s as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497790A1 Rors as modifiers of the p21 pathway and methods of use |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497139A1 Membrane-based assays |
| 03/25/2004 | CA2497132A1 Method of diagnosing ovarian endometriosis |
| 03/25/2004 | CA2496319A1 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | CA2495816A1 Substrate for bioassay, substrate information reader, and substrate information reading method |
| 03/25/2004 | CA2495252A1 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 03/24/2004 | EP1400806A1 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 03/24/2004 | EP1400601A1 Method for detection of multiple nucleic acid sequence variations |
| 03/24/2004 | EP1400599A1 Mass label linked hybridisation probes |
| 03/24/2004 | EP1400598A1 Method of assay of nucleic acid sequences |
| 03/24/2004 | EP1400597A1 Oligonucleotides for amplification and detection of hemochromatosis gene |
| 03/24/2004 | EP1400596A1 Androgen receptor complex-associated protein |
| 03/24/2004 | EP1400595A1 Luciferase detection reagent kits and luciferase detection method using the kits |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400589A1 Method for the enrichment of prokaryotic DNA |
| 03/24/2004 | EP1400588A1 POLYNUCLEOTIDE PROBE AND PRIMER ORIGINATING IN HEPATITIS E VIRUS OF JAPANESE, CHIPS HAVING THE SAME, KITS HAVING THE SAME AND METHOD OF DETECTING HEPATITIS E VIRUS USING THE SAME |
| 03/24/2004 | EP1400247A1 Treatment of endometriosis with antileukoprotease |
| 03/24/2004 | EP1400171A1 Transgenic production of antibodies in milk |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399742A2 Quinacridone labelling reagents for fluorescence detection of biological materials |
| 03/24/2004 | EP1399741A1 Method of mass spectrometry |
| 03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
| 03/24/2004 | EP1399739A2 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 03/24/2004 | EP1399738A2 Glaucoma treatments with reduced hyperpigmentation |
| 03/24/2004 | EP1399733A1 Electrochemical detection of analytes |
| 03/24/2004 | EP1399595A2 Screens for susceptibility to immunodeficiency and viral disease |
| 03/24/2004 | EP1399594A2 In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads |
| 03/24/2004 | EP1399593A2 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 03/24/2004 | EP1399592A1 Method to measure gene expression ratio of key genes |
| 03/24/2004 | EP1399591A2 Method for the determination of telomere length |
| 03/24/2004 | EP1399590A2 Happier mapping |
| 03/24/2004 | EP1399589A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 03/24/2004 | EP1399588A2 Method and sequences for determinate nucleic acid hybridization |
| 03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 03/24/2004 | EP1399586A2 Method to identify genes associated with chronic myelogenous leukemia |
| 03/24/2004 | EP1399585A2 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 03/24/2004 | EP1399584A2 Cancer-linked genes as targets for chemotherapy |
| 03/24/2004 | EP1399582A1 Method for kidney disease detection by protein profiling |
| 03/24/2004 | EP1399581A2 Detection of microbiological contaminants in samples of non-living material |
| 03/24/2004 | EP1399580A1 Secretion of proteins by encapsulated cells |
| 03/24/2004 | EP1399579A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 03/24/2004 | EP1399578A2 Adsls as modifiers of the p53 pathway and methods of use |
| 03/24/2004 | EP1399576A2 Test system for determining gene toxicities |
| 03/24/2004 | EP1399575A2 Methods of modifying eukaryotic cells |
| 03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
| 03/24/2004 | EP1399571A2 Modulating developmental transitions in plants |
| 03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
| 03/24/2004 | EP1399564A2 Drug metabolizing enzymes |
| 03/24/2004 | EP1399561A2 Plant disease resistance genes |
| 03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 03/24/2004 | EP1399542A2 Methods for modulating gap junctions |
| 03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399467A2 Peptide deformylase activated prodrugs |
| 03/24/2004 | EP1399457A1 Processes of purifying oligonucleotides |
| 03/24/2004 | EP1399184A2 Uses of mammalian genes and related reagents |
| 03/24/2004 | EP1250463A4 Sensitive, multiplexed diagnostic assays for protein analysis |
| 03/24/2004 | EP1231934B1 Methods of inhibiting atrophy or promoting hypertrophy |
| 03/24/2004 | EP1218542B1 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 03/24/2004 | EP1180170A4 Polynucleotide arrays and methods of making and using the same |
| 03/24/2004 | EP1176989B1 Method for eliminating legionella from a colonized aqueous flux by electropulsation |